| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968833 | Vaccine | 2011 | 10 Pages |
Abstract
In this initial study, Advax⢠adjuvant formulations improved the protective efficacy of a split-virion H5N1vaccine as measured by significantly enhanced immunogenicity, survival, and reduced morbidity.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
R. Colby Layton, Nikolai Petrovsky, Andrew P. Gigliotti, Zemmie Pollock, Jennifer Knight, Nathaniel Donart, John Pyles, Kevin S. Harrod, Peng Gao, Frederick Koster,